Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Dan Peters | 18,40 | 18,40 | 2025-06-26 |
| Avanza Pension | 4,91 | 4,91 | 2025-06-26 |
| Sparekassen Kronjylland - General Client Account | 1,89 | 1,89 | 2025-06-26 |
| Nordnet Pensionsförsäkring | 1,72 | 1,72 | 2025-06-26 |
| Yan Xiong | 1,70 | 1,70 | 2025-06-26 |
| Che Harald Mårten Vågerö | 1,58 | 1,58 | 2025-06-26 |
| Johan Haag | 1,30 | 1,30 | 2025-06-26 |
| Thomas Khanu | 1,27 | 1,27 | 2025-06-26 |
| Rossen Denmark Aps | 1,19 | 1,19 | 2025-06-26 |
| Ulrika Erhardsson | 1,17 | 1,17 | 2025-06-26 |
